Fire-district

District of Columbia Fire and EMS Department

May be outdated173 dose entries39 drugs1 documentWashington, DCeffective 2024-08-0193% machine-parsed of 173

District of Columbia Fire and EMS Department (Washington, DC) carries 39 drugs across 173 dose entries in its current published protocol, effective 2024-08-01.

The current listed document is more than 24 months old and may be outdated.

Drugs and doses39

Acetaminophen

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	640 mg	PO	not captured	standing	page 188
Mild to moderate pain	peds	1.25 mL	PO	not captured	standing	page 188

Adenosine

Indication	Population	Dose	Route	Repeat	Standing	Source
SVT	adult	6 mg	IV	not captured	standing	page 122
SVT	peds	0.1 mg/kg	IV	not captured	standing	page 122
Wide-complex tachycardia	adult	6 mg	IV	not captured	standing	page 446
Wide-complex tachycardia	peds	0.1 mg/kg	IV	not captured	standing	page 446

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2.5 mg	NEB	not captured	standing	page 145
Asthma / bronchospasm	peds	2.5 mg	NEB	not captured	standing	page 145

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Wide-complex tachycardia	adult	150 mg	IV	not captured	standing	page 449
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	page 449
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	page 449
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	page 449
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	page 449

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	page 130

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	0.5 mg	IV	not captured	standing	page 451
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	page 451
Organophosphate poisoning	adult	2 mg	IM	not captured	standing	page 451
Organophosphate poisoning	peds	0.5 mg	IM	not captured	standing	page 451

Buprenorphine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	8–16 mg	SL	not captured	standing	page 453

Calcium Chloride

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	page 75
Hyperkalemia	peds	20 mg/kg	IV/IO	not captured	standing	page 75
Trauma / hemorrhage	adult	1 g	IV/IO	not captured	standing	page 300

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	100 mL	IV/IO	not captured	standing	page 213
Hypoglycemia	peds	5 mL/kg	IV/IO	not captured	standing	page 213

Diazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Seizure	adult	10 mg	IM	not captured	standing	page 456
Seizure	adult	2–10 mg	IV/IO/IM	not captured	standing	page 456
Seizure	peds	0.3 mg/kg	IV/IO/IM	not captured	standing	page 456
Seizure	peds	10 mg	IM	not captured	standing	page 456

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	25–75 mg	IV/IO/IM	not captured	standing	page 166
Allergic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 166
Dystonic reaction	adult	50 mg	IV/IM	not captured	standing	page 169

Dou-Dote

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	1 auto-injector	IM	not captured	standing	page 320
Nerve agent exposure	peds	1 auto-injector	IM	not captured	standing	page 320
Organophosphate poisoning	adult	1 auto-injector	IM	not captured	standing	page 320
Organophosphate poisoning	peds	1 auto-injector	IM	not captured	standing	page 320

Enalaprilat

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	1.25 mg	IV	not captured	standing	page 135
Other	adult	1.25 mg	IV	not captured	standing	page 458

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3–0.5 mg	IM	not captured	standing	page 165
Anaphylaxis	peds	0.01 mg/kg	IM	not captured	standing	page 165
Asthma / bronchospasm	adult	0.3–0.5 mg	IM	not captured	standing	page 146
Asthma / bronchospasm	peds	0.01 mg/kg	IM	not captured	standing	page 146
Bradycardia	adult	2–10 mcg	IV/IO	not captured	standing	page 128
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	page 75
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	page 75

Esmolol

Indication	Population	Dose	Route	Repeat	Standing	Source
Atrial fibrillation with RVR	adult	0.5 mg/kg	IV/IO	not captured	standing	page 123
VF / pulseless VT	adult	0.5 mg/kg	IV/IO	not captured	standing	page 89

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
Burns	adult	50–100 mcg	IV	not captured	standing	page 132
Burns	peds	1 mcg/kg	IV	not captured	standing	page 132
Mild to moderate pain	adult	25–50 mcg	IV	not captured	standing	page 132
Mild to moderate pain	peds	1 mcg/kg	IV	not captured	standing	page 132

Furosemide

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	20–40 mg	IV	not captured	standing	page 463
CHF / pulmonary edema	adult	20–40 mg	IV	not captured	standing	page 463
CHF / pulmonary edema	peds	0.5 mg/kg	IV	not captured	standing	page 463
CHF / pulmonary edema	peds	0.5 mg/kg	IV	not captured	standing	page 463
Other	adult	20–40 mg	IV	not captured	standing	page 463
Other	peds	0.5 mg/kg	IV	not captured	standing	page 463

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	1 mg	IV/IO/IM/IN	not captured	standing	page 464
Anaphylaxis	peds	0.5 mg	IV/IO/IM/IN	not captured	standing	page 464
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV/IO/IM/IN	not captured	standing	page 464
Beta-blocker / calcium-channel-blocker overdose	adult	1 mg	IV/IO/IM/IN	not captured	standing	page 464
Beta-blocker / calcium-channel-blocker overdose	peds	1 mg	IV/IO/IM/IN	not captured	standing	page 464
Beta-blocker / calcium-channel-blocker overdose	peds	1 mg	IV/IO/IM/IN	not captured	standing	page 464
Hypoglycemia	adult	1 mg	IM/IN	not captured	standing	page 464
Hypoglycemia	peds	0.5 mg	IM/IN	not captured	standing	page 464

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg	IM	not captured	standing	page 467
Agitation	peds	2 mg	IM	not captured	standing	page 467

Hydrocortisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	100 mg	IV/IO/IM	not captured	standing	page 469
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 469

Hydroxocobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV	not captured	standing	page 470
Cyanide poisoning	adult	5 g	IV	not captured	standing	page 470
Cyanide poisoning	peds	70 mg/kg	IV	not captured	standing	page 470
Cyanide poisoning	peds	70 mg/kg	IV	not captured	standing	page 470

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	500 mcg	NEB	not captured	standing	page 145
Asthma / bronchospasm	peds	500 mcg	NEB	not captured	standing	page 145

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	1 mg/kg	IV/IO	not captured	standing	page 67
Cardiac arrest	peds	1 mg/kg	IV/IO	not captured	standing	page 67
Mild to moderate pain	adult	0.2 mg/kg	IV/IO/IM	not captured	standing	page 191
Mild to moderate pain	peds	0.2 mg/kg	IV/IO/IM	not captured	standing	page 191
Procedural sedation	adult	1 mg/kg	IV/IO	not captured	standing	page 439
Procedural sedation	peds	1 mg/kg	IV/IO	not captured	standing	page 439
RSI induction	adult	2 mg/kg	IV/IO	not captured	standing	page 345
RSI induction	peds	2 mg/kg	IV/IO	not captured	standing	page 345

Ketorolac

Indication	Population	Dose	Route	Repeat	Standing	Source
Mild to moderate pain	adult	15 mg	IV	not captured	standing	page 192
Mild to moderate pain	adult	30 mg	IM	not captured	standing	page 192
Mild to moderate pain	peds	0.5 mg/kg	IV	not captured	standing	page 192
Mild to moderate pain	peds	1 mg/kg	IM	not captured	standing	page 192

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	20–40 mg	IO	not captured	standing	page 476
Other	peds	20–40 mg	IO	not captured	standing	page 476
RSI induction	adult	1.5 mg/kg	IV/IO	not captured	standing	page 476
RSI induction	peds	1.5 mg/kg	IV/IO	not captured	standing	page 476
Wide-complex tachycardia	adult	1 mg/kg	IV/IO	not captured	standing	page 476
Wide-complex tachycardia	peds	1 mg/kg	IV/IO	not captured	standing	page 476
VF / pulseless VT	adult	1 mg/kg	IV/IO	not captured	standing	page 475
VF / pulseless VT	adult	1 mg/kg	IV/IO	not captured	standing	page 475
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	page 475
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	page 475

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 g	IV/IO	not captured	standing	page 478
Asthma / bronchospasm	peds	25–50 mg/kg	IV/IO	not captured	standing	page 478
Eclampsia / pre-eclampsia	adult	4 g	IV/IO	not captured	standing	page 478
VF / pulseless VT	adult	2 g	IV/IO	not captured	standing	page 477
VF / pulseless VT	peds	25–50 mg/kg	IV/IO	not captured	standing	page 477

Methylprednisolone

Indication	Population	Dose	Route	Repeat	Standing	Source
Adrenal crisis	adult	125 mg	IV/IO/IM	not captured	standing	page 479
Adrenal crisis	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 479
Asthma / bronchospasm	adult	125 mg	IV/IO/IM	not captured	standing	page 479
Asthma / bronchospasm	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 479
COPD	adult	125 mg	IV/IO/IM	not captured	standing	page 479
COPD	peds	2 mg/kg	IV/IO/IM	not captured	standing	page 479

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	2–5 mg	IV/IN	not captured	standing	page 481
ACS / chest pain	peds	0.1 mg/kg	IV/IN	not captured	standing	page 481
Agitation	adult	10 mg	IN	not captured	standing	page 206
Agitation	adult	2–5 mg	IV/IO	not captured	standing	page 206
Agitation	adult	5 or 10 mg	IM	not captured	standing	page 206
Agitation	peds	0.1 mg/kg	IV/IO	not captured	standing	page 206
Agitation	peds	0.2 mg/kg	IN	not captured	standing	page 206
Agitation	peds	0.2 mg/kg	IM	not captured	standing	page 206
Nerve agent exposure	adult	10 mg	IN	not captured	standing	page 323
Nerve agent exposure	adult	2–5 mg	IV/IO	not captured	standing	page 323
Nerve agent exposure	adult	5 or 10 mg	IM	not captured	standing	page 323
Nerve agent exposure	peds	0.1 mg/kg	IV/IO	not captured	standing	page 323
Nerve agent exposure	peds	0.2 mg/kg	IN	not captured	standing	page 323
Nerve agent exposure	peds	0.2 mg/kg	IM	not captured	standing	page 323
Other	adult	2–5 mg	IV/IO	not captured	standing	page 441
Other	adult	5 mg	IN	not captured	standing	page 441
Other	adult	5 mg	IM	not captured	standing	page 441
Other	peds	0.1 mg/kg	IV/IO	not captured	standing	page 441
Other	peds	0.2 mg/kg	IN	not captured	standing	page 441
Other	peds	0.2 mg/kg	IM	not captured	standing	page 441
Procedural sedation	adult	2–5 mg	IV/IO/IN	not captured	standing	page 481
Procedural sedation	adult	2–5 mg	IV/IO/IN	not captured	standing	page 481
Procedural sedation	peds	0.1 mg/kg	IV/IO/IN	not captured	standing	page 481
Procedural sedation	peds	0.1 mg/kg	IV/IO/IN	not captured	standing	page 481
Seizure	adult	5 mg	IM	not captured	standing	page 202
Seizure	adult	5 mg	IV/IO	not captured	standing	page 202
Seizure	adult	5 mg	IN	not captured	standing	page 202
Seizure	peds	0.1 mg/kg	IV/IO	not captured	standing	page 202
Seizure	peds	0.2 mg/kg	IM	not captured	standing	page 202
Seizure	peds	0.2 mg/kg	IN	not captured	standing	page 202

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	2 mg	IV	not captured	standing	page 132
ACS / chest pain	peds	0.1 mg/kg	IV	not captured	standing	page 132
Burns	adult	2 mg	IV	not captured	standing	page 270
Burns	peds	0.1 mg/kg	IV	not captured	standing	page 270
Mild to moderate pain	adult	2 mg	IV	not captured	standing	page 132
Mild to moderate pain	peds	0.1 mg/kg	IV	not captured	standing	page 132

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Opioid overdose	adult	2 mg	IN	not captured	standing	page 484
Opioid overdose	adult	2 mg	IV/IM/IN	not captured	standing	page 150
Opioid overdose	peds	0.1 mg/kg	IV/IM/IN	not captured	standing	page 150

Nerve Agent Antidote Kit

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	1 kit	IM	not captured	standing	page 321
Nerve agent exposure	peds	1 kit	IM	not captured	standing	page 321
Organophosphate poisoning	adult	1 kit	IM	not captured	standing	page 321
Organophosphate poisoning	peds	1 kit	IM	not captured	standing	page 321

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	page 131
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	page 135
Other	adult	0.4 mg	SL	not captured	standing	page 486

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/IO/IM/ODT	not captured	standing	page 208
Nausea / vomiting	peds	0.15 mg/kg	IV/IO/IM/ODT	not captured	standing	page 208

Oral Glucose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	One single dose tube	PO	not captured	standing	page 466
Hypoglycemia	peds	One single dose tube	PO	not captured	standing	page 466

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	600 mg	IM	not captured	standing	page 490
Organophosphate poisoning	adult	600 mg	IM	not captured	standing	page 490

Prednisone

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	60 mg	PO	not captured	standing	page 491
Asthma / bronchospasm	peds	1–2 mg/kg	PO	not captured	standing	page 491

Racemic Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	0.5 mL	NEB	not captured	standing	page 492
Asthma / bronchospasm	peds	0.25 mL	NEB	not captured	standing	page 492
Croup	adult	0.5 mL	NEB	not captured	standing	page 492
Croup	peds	0.25 mL	NEB	not captured	standing	page 492

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperactive delirium	adult	1 mEq/kg	IV/IO	not captured	standing	page 76
Hyperactive delirium	peds	1 mEq/kg	IV/IO	not captured	standing	page 76
Hyperkalemia	adult	1 mEq/kg	IV/IO	not captured	standing	page 75
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	page 75
Tricyclic overdose	adult	1 mEq/kg	IV/IO	not captured	standing	page 76
Tricyclic overdose	peds	1 mEq/kg	IV/IO	not captured	standing	page 76

Tranexamic Acid

Indication	Population	Dose	Route	Repeat	Standing	Source
Trauma / hemorrhage	adult	1 g	IV/IO	not captured	standing	page 299
Trauma / hemorrhage	peds	25 mg/kg	IV/IO	not captured	standing	page 299

Cite this

District of Columbia Fire and EMS Department, United States EMS Protocol Census. 173 dose entries, effective 2024-08-01.

https://protoquiz.com/census/agencies/district-of-columbia-fire-and-ems-department/

Outdated or wrong?

Send the current document's public URL and the listing is rebuilt from it. To have this agency removed from the census entirely, say so and it comes down the same day.